Before making a mammoth, ask the public
By Victoria Herridge,
Nature
| 10. 20. 2021
Image by Russ Seidel on Flickr
Every few years for the past 20 or so, the story resurfaces, frozen in time like a permafrost carcass. At some future point, typically within the decade, scientists hope to ‘bring back the mammoth’. There have been a few tantalizing results — stirrings in mammoth nuclei transplanted into mouse eggs (K. Yamagata et al. Sci. Rep. 9, 4050; 2019) — but that’s it. Hence raised eyebrows at last month’s announcement by de-extinction champion and geneticist George Church, co-founder (with entrepreneur Ben Lamm) of biotechnology start-up Colossal: yet again, the world has about five years until a wobbly, woolly calf takes its first steps into the Anthropocene.
What Colossal actually aims to produce is less a mammoth than a new synthetic species, a chimaera of Asian elephant DNA and mitochondria, mammoth genetic code and, from the probable surrogate dam, African elephant epigenetics. The resulting cold-adapted elephants — Colossal hopes — will trample and graze northern Siberia to create something akin to the Ice Age grasslands of the woolly mammoth’s heyday. Compacted...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...